HighTower Advisors LLC Has $87.62 Million Stake in CME Group Inc. (NASDAQ:CME)

HighTower Advisors LLC grew its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 0.7% in the 4th quarter, Holdings Channel reports. The fund owned 377,301 shares of the financial services provider’s stock after purchasing an additional 2,554 shares during the quarter. HighTower Advisors LLC’s holdings in CME Group were worth $87,621,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Lake Street Advisors Group LLC increased its holdings in shares of CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock worth $2,949,000 after acquiring an additional 6,453 shares in the last quarter. Meyer Handelman Co. bought a new position in shares of CME Group during the fourth quarter worth about $6,144,000. Spire Wealth Management grew its holdings in shares of CME Group by 37.4% during the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after buying an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc grew its holdings in shares of CME Group by 19.3% during the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after buying an additional 52,862 shares in the last quarter. Finally, Bank of Montreal Can grew its holdings in shares of CME Group by 41.8% during the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after buying an additional 303,169 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CME shares. Royal Bank of Canada increased their price objective on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Barclays increased their price objective on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. JPMorgan Chase & Co. increased their price objective on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Finally, Piper Sandler increased their price objective on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $238.93.

Read Our Latest Stock Analysis on CME

CME Group Stock Performance

CME opened at $256.72 on Thursday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $263.65. The stock has a market cap of $92.51 billion, a price-to-earnings ratio of 26.55, a PEG ratio of 6.76 and a beta of 0.53. The business has a 50 day moving average of $241.74 and a 200-day moving average of $231.77. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.95%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group declared that its board has approved a share buyback program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

Insider Activity

In related news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,076 shares of company stock valued at $4,271,496 over the last three months. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.